Osaka, Japan

Aya Sano

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aya Sano. Retrieved from https://idiyas.com/inventor/aya-sano-oz24bq7i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aya Sano: Innovator in Pharmaceutical Analysis

Introduction

Aya Sano is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical analysis, particularly in the treatment of amyotrophic lateral sclerosis. With a total of 2 patents, her work is paving the way for advancements in medical treatments.

Latest Patents

Aya Sano's latest patents include an analysis method for the active pharmaceutical ingredient 3-methyl-1-phenyl-2-pyrazolin-5-one. This method involves measuring the phenylhydrazine content in the active ingredient through a series of steps that utilize hydrochloric acid and water-soluble organic solvents like acetonitrile and methanol. Additionally, her patents focus on the treatment and inhibition of progression of amyotrophic lateral sclerosis, showcasing her commitment to addressing critical health issues.

Career Highlights

Aya Sano is currently associated with Mitsubishi Tanabe Pharma Corporation, where she continues to innovate in the pharmaceutical sector. Her expertise in analyzing pharmaceutical compounds has positioned her as a valuable asset in her field.

Collaborations

Aya collaborates with Takeshi Wakasugi, further enhancing her research and development efforts in the pharmaceutical industry.

Conclusion

Aya Sano's contributions to pharmaceutical analysis and her innovative patents reflect her dedication to improving medical treatments. Her work is essential in the ongoing fight against amyotrophic lateral sclerosis and highlights the importance of research in healthcare advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…